Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia.

MLA

Dartigeas, Caroline, et al. “Evaluating Abbreviated Induction with Fludarabine, Cyclophosphamide, and Dose-Dense Rituximab in Elderly Patients with Chronic Lymphocytic Leukemia.” Leukemia & Lymphoma, vol. 57, no. 2, Feb. 2016, pp. 328–34. EBSCOhost, https://doi.org/10.3109/10428194.2015.1063139.

APA

Dartigeas, C., Van Den Neste, E., Berthou, C., Maisonneuve, H., Leprêtre, S., Dilhuydy, M.-S., Béné, M.-C., Nguyen-Khac, F., Letestu, R., Cymbalista, F., De Guibert, S., Aurran, T., Laribi, K., Vilque, J.-P., Tournilhac, O., Delmer, A., Feugier, P., Cazin, B., Michallet, A.-S., … Leblond, V. (2016). Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia. Leukemia & Lymphoma, 57(2), 328–334. https://doi.org/10.3109/10428194.2015.1063139

Chicago

Dartigeas, Caroline, Eric Van Den Neste, Christian Berthou, Hervé Maisonneuve, Stéphane Leprêtre, Marie-Sarah Dilhuydy, Marie-Christine Béné, et al. 2016. “Evaluating Abbreviated Induction with Fludarabine, Cyclophosphamide, and Dose-Dense Rituximab in Elderly Patients with Chronic Lymphocytic Leukemia.” Leukemia & Lymphoma 57 (2): 328–34. doi:10.3109/10428194.2015.1063139.